This effect can be blocked with the treatment of the UC1MT antibody, resulting in a marked decrease in diabetes incidence in NOD mice, less leukocyte infiltration into pancreatic islets, and increased levels of circulating insulin. Here, INS is linked to diabetes mellitus.